Please provide your email address to receive an email when new articles are posted on . The novel gene therapy SPK-8011 induced sustained factor VIII expression in patients with hemophilia A, ...
The goal of gene therapy for patients with hemophilia A is to safely impart long-term stable factor VIII expression that predictably ameliorates bleeding with the use of the lowest possible vector ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 6 (Mar., 1990), pp. 2177-2181 (5 pages) Platelet-derived growth factor (PDGF) has been implicated in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results